PREDICTORS OF OPTIMAL MEDICAL THERAPY AND THEIR IMPACT ON MORTALITY AND READMISSION FOR MYOCARDIAL INFARCTION IN STABLE ISCHEMIC HEART DISEASE PATIENTS  by Chun, Soohun et al.
Stable Ischemic Heart Disease
A1532
JACC April 1, 2014
Volume 63, Issue 12
Predictors of oPtimal medical theraPy and their imPact on mortality and readmission 
for myocardial infarction in staBle ischemic heart disease Patients
Oral Contributions
Room 140 A
Sunday, March 30, 2014, 9:15 a.m.-9:30 a.m.
Session Title: Stable Ischemic Heart Disease: Year in Review and Highlighted Clinical Studies
Abstract Category: 25. Stable Ischemic Heart Disease: Clinical
Presentation Number: 915-08
Authors: Soohun Chun, Feng Qiu, Peter C. Austin, Dennis T. Ko, Muhammad Mamdani, Andrew Czarnecki, Duminda N. Wijeysundera, Maria C. 
Bennell, Harindra C. Wijeysundera, University of Toronto, Toronto, Canada
Background: Although randomized studies have shown optimal medical therapy (OMT) to be as efficacious as revascularization in treating stable 
ischemic heart disease (SIHD), the application of routine medical therapy is often sub-optimal. We sought to understand the predictors of receiving 
optimal medical therapy in SIHD, and its impact on outcomes.
methods: Patients with SIHD with their first coronary angiography from October 2008 to September 2011 were identified using the province-wide 
registry in Ontario, Canada. OMT was defined as concurrent use of a β-blocker, ACE Inhibitor/angiotensin receptor blocker and statin. Multivariable 
hierarchical logistic models identified predictors of OMT in the 12 months post-angiography. Cox-proportional hazard models with a time-varying 
covariate for OMT and revascularization status was used to examine differences in death and readmission for non-fatal myocardial infarction (MI) 
as patients moved between four different treatment groups over time: 1) no OMT and no revascularization, 2) no OMT and revascularization, 3) OMT 
and no revascularization, and 4) OMT and revascularization.
results: Our cohort consisted of 20,663 SIHD patients, with a mean follow-up of 2.5 years. Only 61% (n=12,614) of the cohort received OMT 
within 12 months post-angiography. The strongest predictors of receiving OMT included: 1) receiving OMT prior to the angiogram (OR 14.40, CI 
13.17-15.75, p<0.001) and 2) coronary artery bypass surgery post angiogram (CABG) (OR 1.70, CI 1.53-1.89, p<0.001). Relative to patients who 
were not on OMT and not revascularized, patients who were on OMT and revascularized had the greatest reduction in mortality (HR 0.52, CI 0.45-
0.60, p<0.001) and MI (HR 0.74, CI 0.64-0.84, p<0.001). Significant reductions in mortality were also observed in the no OMT and revascularized 
group (HR 0.83, CI 0.69-0.99, p=0.034) and also the OMT and not revascularized group (HR 0.70, CI 0.64-0.77, p<0.001).
conclusion: Our study highlights the low rate of OMT in patients with SIHD, and the importance of baseline prescription of OMT prior to 
angiography. Patients who had both OMT and revascularization achieved the greatest reduction in mortality and readmission for MI.
